Antipsychotic drugs double risk of death among Alzheimer's patients
Friday, January 9, 2009 - 04:21
in Health & Medicine
New research into the effects of antipsychotic drugs commonly prescribed to Alzheimer's patients concludes that the medication nearly doubles risk of death over three years. The study, funded by the Alzheimer's Research Trust, was led by Prof Clive Ballard's King's College London team and is published in Lancet Neurology on 9 January.
Read the whole article on Physorg
More from Physorg
Related
- Antipsychotic drugs double risk of death among Alzheimer's patientsThu, 8 Jan 2009, 19:29:21 EST
- Risk of abnormally slow heart rate twice as high in those taking drugs to slow Alzheimer'sThu, 1 Oct 2009, 15:30:54 EDT
- New study finds healthy children of Alzheimer patients show early brain changesTue, 29 Jul 2008, 0:22:57 EDT
- Ibuprofen linked to reduced risk of Alzheimer's diseaseMon, 5 May 2008, 17:21:47 EDT
- First generation antipsychotic drugs as effective as newer ones in some childrenMon, 15 Sep 2008, 5:36:20 EDT